PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Diabetes drugs affect hearts of men, women differently

2013-12-12
(Press-News.org) Contact information: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Diabetes drugs affect hearts of men, women differently

Widely used treatments for type 2 diabetes have different effects on the hearts of men and women, even as the drugs control blood sugar equally well in both sexes, according to researchers at Washington University School of Medicine in St. Louis.

In particular, the commonly prescribed diabetes drug metformin had positive effects on heart function in women but not in men, who experienced a shift in metabolism thought to increase the risk of heart failure.

"We saw dramatic sex differences in how the heart responds to the different therapies," said senior author Robert J. Gropler, MD, professor of radiology. "Our study suggests that we need to better define which therapies are optimal for women with diabetes and which ones are optimal for men."

The study appears in the December issue of the American Journal of Physiology - Heart and Circulatory Physiology.

To the researchers' knowledge, this is the first study to investigate sex differences in the heart's response to diabetes treatments. In type 2 diabetes, the pancreas continues to make insulin, but the body can't use it effectively to move glucose out of the blood and into the tissues. And for reasons that are not entirely clear, patients with diabetes are at higher risk for heart failure.

"It is imperative that we gain understanding of diabetes medications and their impact on the heart in order to design optimal treatment regimens for patients," said Janet B. McGill, MD, professor of medicine and a study co-author who sees patients at Barnes-Jewish Hospital. "This study is a step in that direction."

The investigators evaluated commonly prescribed diabetes drugs in 78 patients, who were assigned to one of three groups. Under McGill's supervision, the first group received metformin alone; the second received metformin plus rosiglitazone (Avandia); and the third received metformin plus Lovaza, which is a kind of fish oil.

Metformin reduces glucose production by the liver and helps the body become more sensitive to insulin. Rosiglitazone also improves insulin sensitivity and is known to move free fatty acids out of the blood. Lovaza is prescribed to lower blood levels of triglycerides, another type of fat.

Importantly, Gropler noted that when they compared the three groups without separating men and women, no differences in heart metabolism were seen. But when the patients were separated by sex, the drugs had very different and sometimes opposite effects on heart metabolism, even as blood sugar remained well-controlled in all patients.

"The most dramatic difference between men and women is with metformin alone," said Gropler, who also sees patients at Barnes-Jewish Hospital. "Our data show it to have a favorable effect on cardiac metabolism in women and an unfavorable one in men."

The research suggests that these divergent responses in men and women may provide at least a partial explanation for the conflicting data surrounding some diabetes drugs. Specifically, the proportion of men and women participating in a clinical trial may play an unappreciated role in whether drugs are found to be safe and effective.

There is particular controversy surrounding rosiglitazone. In 2010, the U.S. Food and Drug Administration (FDA) restricted rosiglitazone's use because of questions about cardiovascular safety. Based on a recent review of data, the FDA reversed its 2010 decision last month, lifting the restrictions.

In the current study, metformin caused the heart metabolism of men to move in an undesirable direction – burning less sugar and more fats. Chronic burning of fat by the heart, according to Gropler, leads to detrimental changes in the heart muscle, which can lead to heart failure.

"Instead of making heart metabolism more normal in men, metformin alone made it worse, looking even more like a diabetic heart," Gropler said. "But in women, metformin had the desired effect – lowering fat metabolism and increasing glucose uptake by the heart."

Taking either rosiglitazone or Lovaza with metformin seemed to mitigate some of the negative heart effects of metformin alone in men. But women, already benefiting from metformin, improved heart metabolism further by adding rosiglitazone, with the desired effect of reducing the heart's dependence on fat metabolism. Adding Lovaza did not have a strong effect in either direction for men or women.

Gropler pointed out that he and his colleagues have shown in previous work that even healthy men and women show differences in how their hearts burn fuel. Healthy male hearts tend to burn more glucose, while in women, healthy hearts tend to burn more fats. This difference may help explain why women with diabetes tend to get more aggressive heart failure than men: Women already burn more fats.

"We now know there are sex differences at baseline, both in the metabolism of healthy hearts and in the hearts of patients with diabetes," Gropler said. "We are adding the message that these sex differences persist in how patients respond to drugs. For patients with diabetes, we are going to have to be more attentive to sex differences when we design therapies."

Further complicating matters, the researchers also noted that the differences they observed in heart metabolism can't be measured with conventional blood tests.

Unlike many heart studies that rely on blood sugar and cholesterol tests that anyone might get at a doctor visit, the Washington University researchers used positron emission tomography (PET) scans to image the heart and measure blood flow, oxygen consumption and fatty acid and glucose uptake by the heart, among other measures. They also took echocardiograms in conjunction with the PET scans and used stable isotopes to monitor whole-body metabolism and how this influences the heart.

Although the trial was relatively small in terms of the number of patients, it was unusually rigorous in the methods used to analyze heart metabolism, according to Gropler. He noted that only a handful of medical centers worldwide have the resources to perform such a study.

"If you use standard measurements, you're going to miss the sex differences we observed," Gropler said. "This may mean we have to do more complex imaging of the heart to better understand which therapies are best for which patients."



INFORMATION:



This work was supported by the National Institutes of Health (NIH). Grant numbers PO1HL013851-43, MO1-RR000036-461599, P30-DK056341-08 and P60-DK020579-30.

Lyons MR, Peterson LR, McGill JB, Herrero P, Coggan AR, Saeed IM, Recklein C, Schechtman KB, Gropler RJ. Impact of sex on the heart's metabolic and functional responses to diabetic therapies. American Journal of Physiology – Heart and Circulatory Physiology. December 2013.

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.



ELSE PRESS RELEASES FROM THIS DATE:

How bats took over the night

2013-12-12
How bats took over the night Tel Aviv University researchers unlock the secrets of echolocation's relationship to vision Blessed with the power of echolocation — reflected sound — bats rule the night skies. There are more than 1,000 species of these ...

Light and sound fire scientists' imaginations

2013-12-12
Light and sound fire scientists' imaginations Rice researchers lead review of photonic, phononic metamaterials HOUSTON – (Dec. 12, 2013) – Strategies to manipulate light and sound go back to the first spherical glass bead and the pounding of the first hollow log. But their ...

Is smoking cannabis and driving the new drinking and driving?

2013-12-12
Is smoking cannabis and driving the new drinking and driving? Use of prescription, over-the-counter medications also of concern in CAMH's latest Ontario Student Drug Use and Health Survey Toronto - Alcohol consumption and smoking among Ontario students ...

Whooping cough vaccine antigen disappearing from bacteria in US

2013-12-12
Whooping cough vaccine antigen disappearing from bacteria in US Vaccines for whooping cough contain three to five protective antigens, the presence of which are critical to the vaccine's effectiveness. But one of the antigens, pertactin, which had been present ...

Fast radio bursts might come from nearby stars

2013-12-12
Fast radio bursts might come from nearby stars First discovered in 2007, "fast radio bursts" continue to defy explanation. These cosmic chirps last for only a thousandth of a second. The characteristics of the radio pulses suggested ...

A powder to enhance NMR signals

2013-12-12
A powder to enhance NMR signals Towards fast and accurate structure determination by NMR and early cancer diagnosis by MRI Nuclear Magnetic Resonance (NMR) Spectroscopy is an extremely powerful non-destructive technique for the characterization ...

NASA satellite sees Tropical Cyclone Madi make landfall in southeastern India

2013-12-12
NASA satellite sees Tropical Cyclone Madi make landfall in southeastern India As Tropical Cyclone Madi began its landfall in southeastern Tamil Nadu, India NASA's Aqua satellite passed overhead and captured an image of the weakening storm. Several factors are ...

Hubble discovers water vapor venting from Jupiter's moon Europa

2013-12-12
Hubble discovers water vapor venting from Jupiter's moon Europa The NASA/ESA Hubble Space Telescope has discovered water vapour erupting from the frigid surface of Jupiter's moon Europa, in one or more localised plumes near its south pole. Europa ...

Smashing science: Livermore scientists discover how explosives respond to shockwaves

2013-12-12
Smashing science: Livermore scientists discover how explosives respond to shockwaves Lawrence Livermore National Laboratory researchers have combined ultrafast time-resolved experimental measurements with theory to reveal how an explosive responds to ...

For altitude training, a narrow window for success

2013-12-12
For altitude training, a narrow window for success Article is published in the Journal of Applied Physiology Bethesda, Md. (Dec. 12, 2013)—Researchers and athletes have long known that living at altitude holds the potential to improve athletic performance. Many competitive ...

LAST 30 PRESS RELEASES:

AI revives classic microscopy for on-farm soil health testing

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

[Press-News.org] Diabetes drugs affect hearts of men, women differently